BioCardia Inc. (BCDA)
NASDAQ: BCDA
· Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Jun 06, 2025, 10:16 AM
0.94% (1D)
| Bid | 2.1 |
| Market Cap | 11.13M |
| Revenue (ttm) | -55K |
| Net Income (ttm) | -8.39M |
| EPS (ttm) | -2.14 |
| PE Ratio (ttm) | -1 |
| Forward PE | -2.21 |
| Analyst | Buy |
| Ask | 2.26 |
| Volume | 2,153 |
| Avg. Volume (20D) | 81,265 |
| Open | 2.15 |
| Previous Close | 2.13 |
| Day's Range | 2.11 - 2.21 |
| 52-Week Range | 1.63 - 5.04 |
| Beta | 0.84 |
About BCDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-16.25%
BioCardia shares are trading lower after the compa...
Unlock content with
Pro Subscription
4 months ago
+3.65%
BioCardia shares are trading higher after the company announced that the American College of Cardiology 2025 Scientific Sessions accepted the presentation for the results of the double-blind randomized placebo-controlled CardiAMP HF Phase 3 study.
